Latest news for Onyx Gold (OTC:ONXGF) Stock

Onyx Gold corp is an exploration company focused on Canadian mining jurisdictions, with assets in Timmins, Ontario, and Yukon Territory. The company's portfolio of gold projects in the greater Timmins gold camp includes the Munro-Croesus Gold property, for its mineralization, plus two additional earlier-stage large exploration properties, Golden Mile, Yukon, and Timmins South.

Onyx Gold corp

<p><strong>Rivian Automotive, Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) shares are trading higher on Monday after the company opened sales of its commercial electric vans for fleets <a href="https://www.benzinga.com//node/43587398">across the U.S</a>.</p>
<p>The company has been trialing its commercial van with multiple large fleets across the country. These trials have helped Rivian improve its fleet management systems, setting the stage for the wider launch of sales in the U.S.</p>
<p>&#8220;Through existing partnerships our commercial vans have already proved incredibly successful. Amazon currently has more than 20,000 in its fleet and delivered over a billion packages from its Electric Delivery Vans in 2024 alone,&#8221; said <strong>Tom Solomon</strong>, Senior Director, Business Development, Rivian.</p>
<p>The Rivian commercial van is offered in two sizes, the 500 and 700, with a payload capacity of up to 2,663 lbs and a gross vehicle weight rating of up to 9,500 lbs. </p>
<p><strong>What Else:</strong> Rivian is set to release earnings for its 2024 fiscal-year fourth-quarter on February 20 after the market closes. Analysts estimate a loss per share of 65 cents and revenue of $1.4 billion, per data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/25/02/43604668/this-analyst-with-86-accuracy-rate-sees-more-than-18-upside-in-amazon-com-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts">This Analyst With 86% Accuracy Rate Sees More Than 18% Upside In Amazon.com, &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a></strong></p>
<p><strong>RIVN Price Action:</strong> At the time of publication, Rivian shares are trading 3.45% higher at $12.89, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><em>Image: via Shutterstock</em></p>


News

Movers

RIVN

What's Going On With Rivian Shares Monday?

WIIM

AKAM

AVGO

BNAI

CSAI

DELL

INTC

MOBBW

MOBX

NVDA

SPCB

VNET

Shares of companies within the broader tech sector are trading higher amid a possible rebound after falling last week due to AI competition concerns related to China's DeepSeek AI model.

ADBE

APPS

ASAN

CFLT

CMCM

CRNC

ESTC

GRRR

HUBS

KVYO

NISN

ORCL

PLTR

PONY

RBRK

TEAM

VEEA

VRNS

Shares of software companies are trading higher amid a possible rebound after falling last week due to AI competition concerns related to China's DeepSeek AI model.

<p>High-rolling investors have positioned themselves bearish on Procter &amp; Gamble (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in PG often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 10 options trades for Procter &amp; Gamble. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 30% bullish and 60% bearish. Among all the options we identified, there was one put, amounting to $62,845, and 9 calls, totaling $738,573.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $165.0 to $180.0 for Procter &amp; Gamble over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Procter &amp; Gamble's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Procter &amp; Gamble's whale trades within a strike price range from $165.0 to $180.0 in the last 30 days. </p>
<h3>Procter &amp; Gamble 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739218530_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.54</td>
<td>$2.38</td>
<td>$2.43</td>
<td>$180.00</td>
<td>$257.0K</td>
<td>3.5K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$7.7</td>
<td>$7.4</td>
<td>$7.55</td>
<td>$180.00</td>
<td>$113.2K</td>
<td>4.5K</td>
<td>357</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.39</td>
<td>$2.39</td>
<td>$2.39</td>
<td>$180.00</td>
<td>$110.6K</td>
<td>3.5K</td>
<td>1.7K</td>
</tr>
<tr>
<td>PG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$2.4</td>
<td>$2.39</td>
<td>$2.39</td>
<td>$180.00</td>
<td>$98.4K</td>
<td>3.5K</td>
<td>2.1K</td>
</tr>
<tr>
<td>PG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$0.62</td>
<td>$0.61</td>
<td>$0.62</td>
<td>$165.00</td>
<td>$62.8K</td>
<td>2.8K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Procter &amp; Gamble</h3>
<p>Since its founding in 1837, Procter &amp; Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.</p>
<h3>Procter &amp; Gamble's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 3,505,152, the PG's price is down by -0.13%, now at $167.76. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 70 days.</li>
</ul>
<h3>Expert Opinions on Procter &amp; Gamble</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $181.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from JP Morgan persists with their Overweight rating on Procter &amp; Gamble, maintaining a target price of $181.<br />
&#x2A; An analyst from UBS persists with their Buy rating on Procter &amp; Gamble, maintaining a target price of $189.<br />
&#x2A; An analyst from DA Davidson persists with their Buy rating on Procter &amp; Gamble, maintaining a target price of $209.<br />
&#x2A; An analyst from Stifel has decided to maintain their Hold rating on Procter &amp; Gamble, which currently sits at a price target of $161.<br />
&#x2A; An analyst from Stifel persists with their Hold rating on Procter &amp; Gamble, maintaining a target price of $165. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Procter &amp; Gamble, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

What the Options Market Tells Us About Procter & Gamble

<p>Deep-pocketed investors have adopted a bullish approach towards Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SHOP usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 119 extraordinary options activities for Shopify. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 42% leaning bullish and 42% bearish. Among these notable options, 45 are puts, totaling $3,740,750, and 74 are calls, amounting to $7,551,513.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $50.0 and $175.0 for Shopify, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Shopify stands at 1080.54, with a total volume reaching 86,170.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Shopify, situated within the strike price corridor from $50.0 to $175.0, throughout the last 30 days.</p>
<h3>Shopify Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739218525_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$7.95</td>
<td>$7.8</td>
<td>$7.75</td>
<td>$123.00</td>
<td>$1.4M</td>
<td align="right">619</td>
<td>2.0K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$7.25</td>
<td>$7.05</td>
<td>$7.25</td>
<td>$123.00</td>
<td>$1.3M</td>
<td align="right">216</td>
<td>2.4K</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.0</td>
<td>$8.65</td>
<td>$8.7</td>
<td>$85.00</td>
<td>$1.3M</td>
<td align="right">8</td>
<td>2.2K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$22.6</td>
<td>$22.3</td>
<td>$22.45</td>
<td>$100.00</td>
<td>$561.2K</td>
<td align="right">111</td>
<td>1.8K</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/14/25</td>
<td>$18.35</td>
<td>$18.05</td>
<td>$18.2</td>
<td>$105.00</td>
<td>$455.0K</td>
<td align="right">307</td>
<td>1.7K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Shopify</h3>
<p>Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.</p>
<p>In light of the recent options history for Shopify, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Shopify's Current Market Status</h3>
<ul>
<li>With a volume of 9,311,742, the price of SHOP is up 2.38% at $120.2. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 1 days.</li>
</ul>
<h3>Professional Analyst Ratings for Shopify</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $130.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $130.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Shopify options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


SHOP

Unpacking the Latest Options Trading Trends in Shopify

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Coinbase Glb</strong>.</p>
<p>Looking at options history for Coinbase Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) we detected 207 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 34% with bearish.</p>
<p>From the overall spotted trades, 49 are puts, for a total amount of $3,031,142 and 158, calls, for a total amount of $12,794,352.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $2.5 to $690.0 for Coinbase Glb over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Coinbase Glb's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Coinbase Glb's substantial trades, within a strike price spectrum from $2.5 to $690.0 over the preceding 30 days.</p>
<h3>Coinbase Glb Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739218520_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$102.8</td>
<td>$101.75</td>
<td>$102.5</td>
<td>$300.00</td>
<td>$205.0K</td>
<td>294</td>
<td align="right">24</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$97.75</td>
<td>$96.85</td>
<td>$97.75</td>
<td>$310.00</td>
<td>$175.9K</td>
<td>145</td>
<td align="right">20</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$280.85</td>
<td>$277.95</td>
<td>$279.18</td>
<td>$2.50</td>
<td>$139.5K</td>
<td>2.3K</td>
<td align="right">365</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$280.05</td>
<td>$277.85</td>
<td>$278.94</td>
<td>$2.50</td>
<td>$139.4K</td>
<td>2.3K</td>
<td align="right">355</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$280.55</td>
<td>$277.65</td>
<td>$278.8</td>
<td>$2.50</td>
<td>$139.4K</td>
<td>2.3K</td>
<td align="right">350</td>
</tr>
</tbody>
</table>
</p>
<h3>About Coinbase Glb</h3>
<p>Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.</p>
<p>Having examined the options trading patterns of Coinbase Glb, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Coinbase Glb's Current Market Status</h3>
<ul>
<li>With a volume of 4,263,971, the price of COIN is up 1.87% at $279.62. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 3 days.</li>
</ul>
<h3>Expert Opinions on Coinbase Glb</h3>
<p>In the last month, 4 experts released ratings on this stock with an average target price of $302.25.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Mizuho has elevated its stance to Neutral, setting a new price target at $290.<br />
&#x2A; An analyst from Needham persists with their Buy rating on Coinbase Glb, maintaining a target price of $330.<br />
&#x2A; An analyst from Keefe, Bruyette &amp; Woods has decided to maintain their Market Perform rating on Coinbase Glb, which currently sits at a price target of $255.<br />
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Coinbase Glb with a target price of $334. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Coinbase Glb, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


COIN

What the Options Market Tells Us About Coinbase Glb

<p>Globus Medical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>) has outperformed the market over the past 10 years by 2.41% on an annualized basis producing an average annual return of 13.55%. Currently, Globus Medical has a market capitalization of $11.83 billion. </p>
<p><strong>Buying $100 In GMED:</strong> If an investor had bought $100 of GMED stock 10 years ago, it would be worth <strong>$356.36</strong> today based on a price of $86.88 for GMED at the time of writing.</p>
<h3>Globus Medical's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739218511_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Trading Ideas

GMED

$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today

<p><strong>United States Steel Corp.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) shares are trading higher Monday after reports that President <strong>Donald Trump</strong> plans to reinstate 25% tariffs on steel and aluminum imports, a policy aimed at <a href="https://www.benzinga.com/government/regulations/25/02/43592144/us-steel-aluminum-stocks-rally-as-trump-revives-25-tariff-plan">supporting domestic production.</a></p>
<p>Steel and aluminum stocks jumped in response, with major industry players seeing gains in premarket trading. Trump's original tariffs in 2018, imposed under national security justifications, sparked trade tensions and led to retaliatory measures from key U.S. allies. </p>
<p>While the policy boosted domestic producers by raising prices, it drew criticism from trading partners, including Canada and Mexico. The Canadian government reaffirmed its opposition to the tariffs, emphasizing the importance of its steel and aluminum exports to U.S. industries. European steelmakers warned that new tariffs could drive excess supply into their markets.</p>
<p>Markets are now watching for Trump's next steps, as he also suggested introducing reciprocal tariffs in response to trade policies affecting U.S. goods. Previous tariff fluctuations on Canada and Mexico have led to market uncertainty. </p>
<p><strong>X Price Action:</strong> United States Steel shares were up 3.35% at $38.22 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="528" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10142256/Screenshot-2025-02-10-at-14.22.21-1024x528.png" alt="" class="wp-image-775164" style="width:449px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10142256/Screenshot-2025-02-10-at-14.22.21-1024x528.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10142256/Screenshot-2025-02-10-at-14.22.21-300x155.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10142256/Screenshot-2025-02-10-at-14.22.21-768x396.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10142256/Screenshot-2025-02-10-at-14.22.21.png 1527w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/government/regulations/25/02/43603930/tech-stocks-surge-steelmakers-jump-on-trumps-25-tariffs-copper-hits-9-month-highs-whats-driving-markets-monday">Tech Stocks Surge, Steelmakers Jump On Trump&#8217;s 25% Tariffs, Copper Hits 9-Month Highs: What&#8217;s Driving Markets Monday?</a></strong></li>
</ul>
<p><em>Image Via Shutterstock.</em></p>


United States Steel Shares Are Up Today: What's Going On?

<p>On the surface, payment processing specialist <strong>BILL Holdings Inc</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) has no business imploding the way it did last week. On Thursday, the company posted <a href="https://www.benzinga.com/news/earnings/25/02/43547695/bill-holdings-stock-plunges-on-q2-earnings-whats-going-on">fiscal second-quarter financial results</a>, generating revenue of $362.55 million and adjusted earnings per share of 56 cents. These stats beat analysts' consensus estimates of $360.23 million and 46 cents, respectively. Nevertheless, BILL stock tanked following the results.</p>
<p>Even breaking down certain elements, it wasn't readily apparent for those unfamiliar with the broader context why the payment processor stumbled. For example, total revenue increased 14% year-over-year while core revenue — which consists of subscription and transaction fees — climbed 16%. Further, BILL ended the quarter with $1.57 billion in cash and cash equivalents.</p>
<p>Providing an intriguing framing of the results, management articulated that it is seeking "to empower small and mid-sized businesses," a segment that falls under BILL's bread and butter. The kicker was that the company raised its full-year outlook to revenue of $1.45 billion to $1.47 billion. This guidance compares favorably to the prior estimate of $1.46 billion.</p>
<p>Despite these seemingly stellar numbers, BILL stock imploded on Friday, begging the obvious question — why? KeyBanc analysts Alex Markgraff may have summed up the situation the best, stating that his <a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43568285/bills-post-earnings-selloff-analysts-weigh-fx-headwinds-take-rate-woes">prior expectations of growth were off</a> and that BILL deserved its equity erosion. Other analysts alluded to Q3 guidance being flat rather than anything game-changing.</p>
<p>Generally speaking, the Q2 results were good, but concerns started to creep in about slowing sales growth. In addition, BILL's exposure to small and mid-sized businesses (SMBs) may have spooked investors, amid some fears of significant <a href="https://www.benzinga.com/news/24/12/42735416/el-erian-warns-of-hidden-crisis-in-exceptional-us-economy-as-lower-income-households-face-considerable-challenges">economic challenges</a>.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/news/global/25/02/43604572/jd-vance-quarterbacking-tiktok-deal-will-his-venture-capital-experience-secure-a-win">JD Vance &#8216;Quarterbacking&#8217; TikTok Deal: Will His Venture Capital Experience Secure A Win?</a></strong></p>
<h2 class="wp-block-heading">BILL Stock Now Presents a Tempting Value Proposition</h2>
<p>Given the broader context, the question isn't so much about whether BILL stock deserved to have a reduction in the share price; rather, it's about the magnitude of the decline. Prior to the selloff, BILL traded hands near the $100 level. At time of writing, it's exchanging hands at around $65. This implosion has value hunters salivating.</p>
<p>Presently, BILL stock carries a trailing earnings multiple of <a href="https://finance.yahoo.com/quote/BILL/key-statistics/">over 159 times</a>. However, on a forward basis, BILL trades at just under 37 times earnings. As well, assuming revenue lands at the guidance midpoint of $1.46 billion, the equity is priced at only 4.63 times projected sales. During the first calendar quarter last year, the sales multiple averaged 6.13 times.</p>
<p>Yes, economic concerns linger, and BILL's exposure to SMBs presents a risk factor. However, it's also fair to point out that while the <a href="https://www.benzinga.com/news/econ-s/25/02/43565669/january-jobs-report-not-too-hot-not-too-cold-leaves-interest-rate-cuts-unlikely-expert">January jobs report</a> came in technically below expectations, overall jobs growth in December was <a href="https://www.benzinga.com/news/25/01/42934513/job-growth-fed-jitters-and-rising-mortgage-rates-this-week-in-economics">unusually strong</a>. Amid the noise within the data, some analysts argue that the labor market stands on solid ground.</p>
<p>Still, the most compelling argument could be the statistical data undergirding BILL stock. Using data from the past five years, BILL demonstrates an upward bias. A position entered at the beginning of the week has a 52.12% chance of rising by the end of it. Over a four-week period, the long odds improve to 54.47%.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10143450/BILL-stock-probability-gambit-1024x576.jpg" alt="" class="wp-image-775184" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10143450/BILL-stock-probability-gambit-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10143450/BILL-stock-probability-gambit-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10143450/BILL-stock-probability-gambit-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10143450/BILL-stock-probability-gambit.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption"><em>Image by author</em></figcaption></figure></p>
<p>Even more enticing, rather than viewing the data from a simple stochastic or temporal framework, one can filter the data through a dynamic lens. Last week, BILL stock dropped 33.83% — an extreme-fear event if there ever was one. Whenever BILL has lost 10% or more in a one-week period (in the past five years), there's a 60.71% chance that it will rise one week later. Over four weeks, the long odds soar to 78.57%.</p>
<h2 class="wp-block-heading">Strategizing a Bullish Options Trade</h2>
<p>One critical caveat to the high long odds is that the median return under the positive scenario isn't particularly remarkable. Four weeks following an extreme-fear event (losing 10% or more in one week), the median return is 8.34%. That comes out to $67.31 based on Friday's closing price, which is lower than the $69.24 target, which would be calculated using a stochastic framework.</p>
<p>Without getting too deep into the weeds, it's likely that market makers are anticipating a rebound in BILL stock. Therefore, the call options are probably priced at a richer-than-normal premium. Because of this situation, it may be better to consider a narrower <a href="https://www.benzinga.com/money/bull-spread">bull call spread</a>. While this approach greatly exacerbates the risk that the entire spread will expire completely worthless, the net debit required for a wider and thereby more "protective" spread may be onerous.</p>
<p>With that in mind, one idea to consider is the 64/67 bull call spread (buy the $64 call, simultaneously sell the $67 call) for the options chain expiring March 7. Since BILL stock realistically has a chance of poking its head above $67 by expiration, the short call strike price gives the trader a strong chance of attaining the maximum payout (which at time of writing stands at around 87%).</p>
<p>Also, the $64 long call provides the potential opportunity of salvageable value if the bullish thesis doesn't quite pan out. Out of the available call spreads, the 64/67 spread may be among the most sensible given the circumstances.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43605038/coca-cola-stock-is-bubbling-higher-can-q4-earnings-keep-the-fizz-going"><strong>Coca-Cola Stock Is Bubbling Higher: Can Q4 Earnings Keep The Fizz Going?</strong></a></li>
</ul>
<p><em>Photo: Ground Picture/Shutterstock.com</em></p>


Earnings Beats

Long Ideas

BILL

Options Corner: Bill Holdings' Post-Earnings Implosion Gives Speculators A Discounted Long Trade

<p>In a rapidly evolving cannabis industry, where social equity remains an ongoing challenge, <strong>Standard Wellness Maryland</strong> is making history. Led by <strong>Christina Betancourt Johnson,</strong> the company is the first African American and Latina majority-owned, vertically integrated cannabis company in the United States—as confirmed by the company with the social equity office in Maryland.</p>
<p>Now, with the opening of <strong>The Forest</strong> in Baltimore's Canton neighborhood, Johnson and her team are bringing their vision of wellness, community and representation to life.</p>
<p>&#8220;We are incredibly honored to break new ground in Maryland&#8217;s retail cannabis landscape,&#8221; said Johnson, who also serves as the company's CEO. "Our promise is to promote wellness and empower our community by being a trusted source for holistic well-being."</p>
<h3 class="wp-block-heading">A Business Rooted In Representation</h3>
<p>The Forest represents the culmination of years of effort to create opportunities in an industry that has historically marginalized people of color. The cannabis sector, despite its multi-billion-dollar valuation, still sees <a href="https://mjbizdaily.com/women-minority-cannabis-executives-rebound-to-pre-pandemic-levels/">minority ownership as an exception rather than the rule</a>. The launch of The Forest is a tangible step toward reversing that imbalance.</p>
<p>"This moment is not just about one business—it's a step toward leveling the playing field and fostering inclusive growth across our economy," said <strong>Delegate C.T. Wilson,</strong> chairman of the <strong>Economic Matters Committee</strong> and co-sponsor of Maryland's House Bill 556, which established <a href="https://www.benzinga.com/cannabis">adult-use cannabis</a> in the state.</p>
<p>For Johnson, representation isn't just about ownership, it's about creating an ecosystem where diverse voices shape the industry. With leadership positions on the <strong>U.S. Cannabis Council</strong> and the <strong>National Hispanic Cannabis Council,</strong> as well as a role as vice chair of <strong>The Maryland Wholesale Cannabis Trade Association (CANMD), </strong>she has been a consistent advocate for minority participation in the cannabis space.</p>
<p>Her work caught the attention of Maryland's governor, <strong>Wes Moore,</strong> who appointed her to the Advisory Board on Medical and Adult-Use Cannabis, a key regulatory body shaping the future of cannabis in the state.</p>
<h3 class="wp-block-heading">The Forest: A Dispensary Designed For Community</h3>
<p>In Baltimore's historic Canton neighborhood, The Forest is more than a retail location. It's a wellness hub where customers can explore cannabis in a welcoming, education-focused environment. With a carefully curated selection of high-quality, sustainable products, the dispensary serves both medical patients and adult-use consumers, prioritizing their needs with a thoughtful approach.</p>
<p><figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions-1024x683.jpeg" alt="" class="wp-image-775111" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions-1024x683.jpeg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions-300x200.jpeg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions-768x512.jpeg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions-1536x1025.jpeg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/10134419/The-Forest_008_PhotoCredit_TeemingVisions.jpeg 1619w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure></p>
<p>"The Forest is where everyone can pursue their wellness journey with support and empowerment," Johnson explained.</p>
<p>From the start, The Forest prioritized building relationships with the local community. <strong>Amanda Bourgeois,</strong> president of the <strong>Canton Community Association, </strong>recognized the company&#8217;s efforts early on.</p>
<p>"The Forest Dispensary has taken a thoughtful approach to becoming a valued partner within our community by engaging with the Canton Community Association early on," she said. "Their commitment to total wellness and collaboration reflects a dedication to contributing meaningfully to both our neighborhood and the broader Baltimore community."</p>
<h3 class="wp-block-heading">A Grand Opening With Purpose</h3>
<p>The grand opening of The Forest earlier this year was a ribbon-cutting ceremony that carried deeper significance—a celebration of perseverance and progress. The event brought together lawmakers, local leaders and the community for speeches, live entertainment, meet-and-greets and a showcase of local food vendors.</p>
<p>For many, this new business stands as a testament to what's possible when equity initiatives take root and create real opportunities.</p>
<p>"When businesses like these thrive, so does the broader community," said Wilson.</p>
<p>As cannabis continues its march toward mainstream acceptance, Standard Wellness Maryland is setting a precedent. With a clear mission, deep community ties and an unwavering commitment to equity, The Forest is making history while actively shaping the future of the industry.</p>
<p><em>Photo by Teeming Visions, courtesy of Standard Wellness Maryland</em></p>


Cannabis

Retail Sales

Inside The First Black And Latina-Owned Vertically Integrated Cannabis Company In The US

<p>In the latest quarter, 26 analysts provided ratings for Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>), showcasing a mix of bullish and bearish perspectives.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">8</td>
<td align="right">7</td>
<td align="right">10</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Cloudflare and provided 12-month price targets. The average target is $145.08, accompanied by a high estimate of $185.00 and a low estimate of $68.00. Surpassing the previous average price target of $111.38, the current average has increased by 30.26%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217664_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Cloudflare by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$160.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Aaron Samuels</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$170.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$115.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$149.00</td>
<td>$111.00</td>
</tr>
<tr>
<td>Gabriela Borges</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$183.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Trevor Walsh</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$180.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>John Difucci</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Sell</td>
<td>$68.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$175.00</td>
<td>$136.00</td>
</tr>
<tr>
<td>Roger Boyd</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$165.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$153.00</td>
<td>$92.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$185.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$160.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Shrenik Kothari</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Andrew Nowinski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$110.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$145.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Andrew Nowinski</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Matt Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$123.00</td>
<td>$99.00</td>
</tr>
<tr>
<td>Gabriela Borges</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Brent Thill</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$125.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Adam Borg</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$136.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$125.00</td>
<td>$102.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$92.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cloudflare. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Cloudflare compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of Cloudflare's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Cloudflare's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NET/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Cloudflare analyst ratings.</strong></a></p>
<h2>All You Need to Know About Cloudflare</h2>
<p>Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.</p>
<h3>Unraveling the Financial Story of Cloudflare</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Cloudflare's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>28.15%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> Cloudflare's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-3.56%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Cloudflare's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>-1.65%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Cloudflare's ROA excels beyond industry benchmarks, reaching <strong>-0.51%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Cloudflare's debt-to-equity ratio is below the industry average at <strong>1.49</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

Demystifying Cloudflare: Insights From 26 Analyst Reviews

<p>5 analysts have expressed a variety of opinions on CNO Finl Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNO#NYSE">CNO</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for CNO Finl Group, presenting an average target of $42.8, a high estimate of $46.00, and a low estimate of $38.00. This upward trend is evident, with the current average reflecting a 5.68% increase from the previous average price target of $40.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217647_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>A clear picture of CNO Finl Group's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$46.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Jack Matten</td>
<td>BMO Capital</td>
<td>Announces</td>
<td>Market Perform</td>
<td>$38.00</td>
<td>-</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$44.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$41.00</td>
<td>$36.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to CNO Finl Group. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CNO Finl Group compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Capture valuable insights into CNO Finl Group's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CNO/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CNO Finl Group analyst ratings.</strong></a></p>
<h2>Discovering CNO Finl Group: A Closer Look</h2>
<p>CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.</p>
<h3>CNO Finl Group: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> CNO Finl Group's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>19.21%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>0.82%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> CNO Finl Group's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>0.36%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> CNO Finl Group's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.03%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> CNO Finl Group's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.6</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


5 Analysts Have This To Say About CNO Finl Group

<p>17 analysts have expressed a variety of opinions on Axsome Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXSM#NASDAQ">AXSM</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">11</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $149.24, along with a high estimate of $190.00 and a low estimate of $116.00. This upward trend is apparent, with the current average reflecting a 2.88% increase from the previous average price target of $145.06.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217639_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Axsome Therapeutics among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$133.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$137.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Joon Lee</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$143.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$190.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Brian Abrahams</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$139.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$133.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Joon Lee</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$180.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$133.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Graig Suvannavejh</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$122.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Charles Duncan</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$121.00</td>
<td>$121.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Raghuram Selvaraju</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$180.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Joel Beatty</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$116.00</td>
<td>$112.00</td>
</tr>
<tr>
<td>Ami Fadia</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Axsome Therapeutics. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Axsome Therapeutics compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Axsome Therapeutics's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Axsome Therapeutics's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AXSM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Axsome Therapeutics analyst ratings.</strong></a></p>
<h2>Get to Know Axsome Therapeutics Better</h2>
<p>Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.</p>
<h3>Axsome Therapeutics's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Axsome Therapeutics displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>81.27%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Axsome Therapeutics's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-61.67%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Axsome Therapeutics's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-66.0%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-11.64%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Axsome Therapeutics's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>2.07</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


AXSM

Beyond The Numbers: 17 Analysts Discuss Axsome Therapeutics Stock

<p>During the last three months, 36 analysts shared their evaluations of Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">11</td>
<td align="right">11</td>
<td align="right">1</td>
<td align="right">6</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">3</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Tesla, presenting an average target of $362.72, a high estimate of $550.00, and a low estimate of $24.86. This upward trend is apparent, with the current average reflecting a 20.94% increase from the previous average price target of $299.91.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217629_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Tesla by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$474.00</td>
<td>$492.00</td>
</tr>
<tr>
<td>Ronald Jewsikow</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Sell</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Joseph Spak</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$259.00</td>
<td>$226.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$515.00</td>
<td>$515.00</td>
</tr>
<tr>
<td>Tom Narayan</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$440.00</td>
<td>$440.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$440.00</td>
<td>$480.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$373.00</td>
<td>$351.00</td>
</tr>
<tr>
<td>Andres Sheppard</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$425.00</td>
<td>$365.00</td>
</tr>
<tr>
<td>Colin Langan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Ronald Jewsikow</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Sell</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Andres Sheppard</td>
<td>Cantor Fitzgerald</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$365.00</td>
<td>$365.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$550.00</td>
<td>$515.00</td>
</tr>
<tr>
<td>Alexander Potter</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$500.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Dan Levy</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$325.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$430.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$490.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$492.00</td>
<td>$411.00</td>
</tr>
<tr>
<td>Chris McNally</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$275.00</td>
<td>$195.00</td>
</tr>
<tr>
<td>George Gianarikas</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$404.00</td>
<td>$298.00</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$351.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Gordon Johnson</td>
<td>GLJ Research</td>
<td>Maintains</td>
<td>Sell</td>
<td>$24.86</td>
<td>$24.86</td>
</tr>
<tr>
<td>William Stein</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Hold</td>
<td>$360.00</td>
<td>$360.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$480.00</td>
<td>$280.00</td>
</tr>
<tr>
<td>Vijay Rakesh</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$515.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Mark Delaney</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$345.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Andres Sheppard</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$365.00</td>
<td>$255.00</td>
</tr>
<tr>
<td>Adam Jonas</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$400.00</td>
<td>$310.00</td>
</tr>
<tr>
<td>Edison Yu</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$370.00</td>
<td>$295.00</td>
</tr>
<tr>
<td>Ronald Jewsikow</td>
<td>Guggenheim</td>
<td>Raises</td>
<td>Sell</td>
<td>$175.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>John Murphy</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$400.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Craig Irwin</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$380.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Stephen Gengaro</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$411.00</td>
<td>$287.00</td>
</tr>
<tr>
<td>Joseph Spak</td>
<td>UBS</td>
<td>Raises</td>
<td>Sell</td>
<td>$226.00</td>
<td>$197.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$400.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Tom Narayan</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$313.00</td>
<td>$249.00</td>
</tr>
<tr>
<td>Philippe Houchois</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$300.00</td>
<td>$195.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Tesla. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tesla compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Tesla's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Tesla's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Tesla analyst ratings.</strong></a></p>
<h2>All You Need to Know About Tesla</h2>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<h3>Unraveling the Financial Story of Tesla</h3>
<p><strong>Market Capitalization Analysis:</strong> With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.</p>
<p><strong>Revenue Growth:</strong> Tesla's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>2.15%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Tesla's net margin excels beyond industry benchmarks, reaching <strong>9.0%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Tesla's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>3.24%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>1.91%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.19</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TSLA

Where Tesla Stands With Analysts

<p><strong>Dollar Gen's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) short percent of float has fallen 7.13% since its last report. The company recently reported that it has <strong>10.13 million shares sold short</strong>, which is 5.21% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.63 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Dollar Gen Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217623_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Dollar Gen has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Dollar Gen's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Dollar Gen's peer group average for short interest as a percentage of float is 3.97%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

(DG) - Analyzing Dollar Gen's Short Interest

<p>Ratings for Mach Natural Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNR#NYSE">MNR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $23.75, a high estimate of $25.00, and a low estimate of $23.00. Observing a 6.36% increase, the current average has risen from the previous average price target of $22.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217621_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>A comprehensive examination of how financial experts perceive Mach Natural Resources is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Selman Akyol</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$23.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$24.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$23.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Mach Natural Resources. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Mach Natural Resources compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of Mach Natural Resources's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Mach Natural Resources's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MNR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Mach Natural Resources analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Unveiling the Story Behind Mach Natural Resources</h2>
<p>Mach Natural Resources LP is an independent upstream oil and gas company focused on the acquisition, development and production of oil, natural gas and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas and the panhandle of Texas.</p>
<h3>A Deep Dive into Mach Natural Resources's Financials</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Mach Natural Resources displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>45.7%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Mach Natural Resources's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>26.39%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Mach Natural Resources's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>5.77%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Mach Natural Resources's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>2.96%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> Mach Natural Resources's debt-to-equity ratio is notably higher than the industry average. With a ratio of <b>0.64</b>, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Beyond The Numbers: 4 Analysts Discuss Mach Natural Resources Stock

<p><strong>Lockheed Martin's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) short percent of float has fallen 9.87% since its last report. The company recently reported that it has <strong>2.73 million shares sold short</strong>, which is 1.37% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 2.37 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Lockheed Martin Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217618_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Lockheed Martin has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.</p>
<h3>Comparing Lockheed Martin's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Lockheed Martin's peer group average for short interest as a percentage of float is 3.67%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Looking Into Lockheed Martin's Recent Short Interest

<p>Analysts' ratings for Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) over the last quarter vary from bullish to bearish, as provided by 6 analysts.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high estimate of $83.00, and a low estimate of $74.00. This current average represents a 1.4% decrease from the previous average price target of $78.60. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217614_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of Equity Residential among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$76.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$75.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$83.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$74.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$83.00</td>
<td>-</td>
</tr>
<tr>
<td>Nicholas Yulico</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$78.00</td>
<td>$81.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Equity Residential. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Equity Residential compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Equity Residential's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into Equity Residential's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EQR/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Equity Residential analyst ratings.</strong></a></p>
<h2>Delving into Equity Residential's Background</h2>
<p>Equity Residential owns a portfolio of 299 apartment communities with around 80,000 units and is developing three additional properties with 977 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.</p>
<h3>Equity Residential: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Equity Residential's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately <strong>2.46%</strong>. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.</p>
<p><strong>Net Margin:</strong> Equity Residential's net margin is impressive, surpassing industry averages. With a net margin of <strong>54.61%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Equity Residential's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>3.83%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Equity Residential's ROA excels beyond industry benchmarks, reaching <strong>2.01%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Equity Residential's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.76</strong>.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Deep Dive Into Equity Residential Stock: Analyst Perspectives (6 Ratings)

<p><strong>Novavax's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NYSE">NVAX</a>) short percent of float has risen 3.13% since its last report. The company recently reported that it has <strong>38.07 million shares sold short</strong>, which is 29.64% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 6.27 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest"><strong>List of the most shorted stocks</strong></a></p>
<h3>Novavax Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217612_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Novavax has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Novavax's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Novavax's peer group average for short interest as a percentage of float is 15.25%, which means the company has <strong>more</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


NVAX

(NVAX) - Analyzing Novavax's Short Interest

<p>Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) has outperformed the market over the past 20 years by 3.94% on an annualized basis producing an average annual return of 12.35%. Currently, Ross Stores has a market capitalization of $47.04 billion. </p>
<p><strong>Buying $1000 In ROST:</strong> If an investor had bought $1000 of ROST stock 20 years ago, it would be worth <strong>$10,302.42</strong> today based on a price of $142.59 for ROST at the time of writing.</p>
<h3>Ross Stores's Performance Over Last 20 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1739217610_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ROST

Here's How Much You Would Have Made Owning Ross Stores Stock In The Last 20 Years

Press Releases

Onyx Gold Receives Drill Permit for King Tut Project and Provides 2024 Exploration Program Update

ONXGF

TSXV:ONYX

Onyx Gold

Comments

Onyx Gold

News

Latest news for Onyx Gold (OTC:ONXGF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga